Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exelixis

44.65
+7.7020.84%
Post-market: 44.710.0600+0.13%18:28 EDT
Volume:12.91M
Turnover:567.89M
Market Cap:12.30B
PE:25.37
High:45.29
Open:40.65
Low:40.47
Close:36.95
Loading ...

Exelixis initiated dose-escalation stage of first human Phase 1 study of XB628

TIPRANKS
·
Yesterday

Exelixis Inc. Initiates Phase 1 Clinical Trial for First-in-Class Bispecific Antibody XB628 in Advanced Solid Tumors

Reuters
·
Yesterday

Exelixis Sees Higher Demand for Flagship Cancer Drug -- Market Talk

Dow Jones
·
Yesterday

Exelixis Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Yesterday

Stock Track | Exelixis Shares Soar 6.63% After-Hours on Strong Q1 Results and Raised 2025 Guidance

Stock Track
·
Yesterday

Stock Track | Exelixis Soars 6.63% After Hours on Strong Q1 Results and Raised 2025 Guidance

Stock Track
·
Yesterday

Exelixis Q1 Non-GAAP Earnings, Revenue Rise; 2025 Revenue Outlook Lifted -- Shares Up After Hours

MT Newswires Live
·
Yesterday

Exelixis Q1 Adj. EPS $0.62 Beats $0.36 Estimate, Sales $555.45M Beat $498.18M Estimate

Benzinga
·
Yesterday

Exelixis Guides For FY 2025 Revenue of $2.25-$2.35 Billion, vs Prior Guidance of $2.15-$2.25 Billion and FactSet Analyst Consensus of $2.25 Billion

MT Newswires Live
·
Yesterday

Exelixis Inc. Reports Q1 2025 Revenue Surge to $555.4M; Non-GAAP EPS Climbs to $0.62

Reuters
·
Yesterday

BRIEF-Exelixis Q1 Revenue USD 555.4 Million Vs. IBES Estimate USD 498.2 Million

Reuters
·
Yesterday

Exelixis Inc: Increasing 2025 Full Year Net Product Revenues and Total Revenues Guidance by $100 Mln

THOMSON REUTERS
·
Yesterday

Exelixis Inc Outlook FY Total Revenues $2.25 Bln - $2.35 Bln

THOMSON REUTERS
·
Yesterday

Exelixis options imply 5.9% move in share price post-earnings

TIPRANKS
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Exelixis Inc expected to post earnings of 36 cents a share - Earnings Preview

Reuters
·
10 May

Here's Why Exelixis (EXEL) is a Strong Momentum Stock

Zacks
·
02 May

Press Release: Exelixis to Release First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Dow Jones
·
30 Apr

U.S. RESEARCH ROUNDUP-Domino's Pizza, Prologis, Springworks Therapeutics

Reuters
·
29 Apr

Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), ImmunityBio (IBRX) and Exelixis (EXEL)

TIPRANKS
·
28 Apr